FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...
Concerns arise over IV cannula quality in Tamil Nadu hospitals, with incidents of breakage leaving fragments inside patients’ veins.
The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with ...
Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in ...
GEN2 was evaluated in adult patients with advanced solid tumors in an intravenous dose escalation Phase 1 study GEN2 is well-tolerated, with no Dose Limiting Toxicity or treatment-related ...
A look at the diagnostic approach to canine vestibular disease, from the initial exam to the challenges of peripheral vs.
PHM continues to advance with diverse research impacting clinical care, quality improvement, and health equity. The top 10 ...
Medicare administrative contracts have proposed eliminating coverage for peripheral nerve block procedures for chronic pain disorders.
The forecasted growth highlights significant opportunities for manufacturers to engage in a rapidly evolving market that is ...
"A patient undergoing IV therapy at Ebo2 Therapy and Wellness in Los Angeles."Los Angeles medical facility documents significant recovery rates in peripheral neuropathy patients using EBOO blood ...
Abstract: Peripheral intravenous catheters fail frequently, with some estimates of failure rates as high as 50% globally. In this letter, the potential for using force-sensitive resistors (FSRs) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback